BIOTRONIK Pulsar-35 Peripheral Self Expanding Stent System Singapore - English - HSA (Health Sciences Authority)

biotronik pulsar-35 peripheral self expanding stent system

biotronik asia pacific pte. ltd. - cardiovascular - the pulsar-35 peripheral self expanding stent system is indicated for use in patients with atherosclerotic disease of the femoral and proximal popliteal arteries, in particular for the treatment of insufficient results after percutaneous transluminal angioplasty (pta), e.g. residual stenosis and dissection.

BIOTRONIK Dynamic Peripheral Stent and Delivery System Singapore - English - HSA (Health Sciences Authority)

biotronik dynamic peripheral stent and delivery system

biotronik asia pacific pte. ltd. - cardiovascular - the dynamic peripheral stent and delivery system is indicated for the treatment of de novo or restenotic atherosclerotic lesions in iliac arteries.

Biotronik Inlexa implantable cardioverter defibrillator Singapore - English - HSA (Health Sciences Authority)

biotronik inlexa implantable cardioverter defibrillator

biotronik asia pacific pte. ltd. - cardiovascular - biotronik implantable cardioverter defibrillators (icds) are intended to treat life-threatening ventricular arrhythmias with antitachycardia pacing and defibrillation

Biotronik Intica Implantable Cardioverter Defibrillator Singapore - English - HSA (Health Sciences Authority)

biotronik intica implantable cardioverter defibrillator

biotronik asia pacific pte. ltd. - cardiovascular - biotronik implantable cardioverter defibrillators (icds) are intended to treat life-threatening ventricular arrhythmias with antitachycardia pacing and defibrillation

BIOTRONIK Astron Peripheral Self Expanding Nitinol Stent System Singapore - English - HSA (Health Sciences Authority)

biotronik astron peripheral self expanding nitinol stent system

biotronik asia pacific pte. ltd. - cardiovascular - is indicated for use in patients with atherosclerotic disease of the iliac arteries and for the treatment of insufficient results after percutaneous transluminal angioplasty (pta), e.g. residual stenosis and dissection.

Biotronik Cruiser Coronary and Peripheral Artery Guidewires Singapore - English - HSA (Health Sciences Authority)

biotronik cruiser coronary and peripheral artery guidewires

biotronik asia pacific pte. ltd. - cardiovascular - cruiser guide wires are indicated to facilitate the placement of interventional catheters with compatible guide wire lumen during an interventional procedure in coronary and peripheral arteries.

Biotronik Cruiser Hydro Coronary and Peripheral Artery Guide Wire Singapore - English - HSA (Health Sciences Authority)

biotronik cruiser hydro coronary and peripheral artery guide wire

biotronik asia pacific pte. ltd. - cardiovascular - are indicated to facilitate the placement of interventional catheters with compatible guide wire lumen during an interventional procedure in coronary and peripheral arteries.

Biotronik Dynamic Renal Stent System Singapore - English - HSA (Health Sciences Authority)

biotronik dynamic renal stent system

biotronik asia pacific pte. ltd. - cardiovascular - the dynamic renal stent system is indicated for improving arterial luminal diameter in patients with clinical symptoms attributable to atherosclerotic stenosis of the renal arteries.

Biotronik Magmaris Sirolimus-Eluting Resorbable Coronary Magnesium Scaffold System Singapore - English - HSA (Health Sciences Authority)

biotronik magmaris sirolimus-eluting resorbable coronary magnesium scaffold system

biotronik asia pacific pte. ltd. - cardiovascular - is indicated for improving luminal diameter in the treatment of de novo native coronary artery lesions in patients with symptomatic coronary artery disease. the reference vessel diameter should closely match the scaffold nominal diameter. the treated lesion length should be less than the nominal scaffold length.

Biotronik Orsiro Sirolimus-Eluting Coronary Stent System Singapore - English - HSA (Health Sciences Authority)

biotronik orsiro sirolimus-eluting coronary stent system

biotronik asia pacific pte. ltd. - cardiovascular - the orsiro sirolimus eluting coronary stent system is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease due to discrete de-novo stenotic lesions and in-stent restenotic lesions (length ≤ 40 mm) in native coronary arteries with a reference vessel diameter of 2.25 mm to 4.0 mm.